Adalimumab effective for juvenile rheumatoid arthritis

Author：  

Publisher： Adis International

ISSN： 1173-8324

Source： Inpharma, Vol.1, Iss.1653, 2008-01, pp. : 13-13

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Adalimumab is an effective option in the treatment of patients with refractory rheumatoid arthritis

By Adis International Limited  

Drugs & Therapy Perspectives, Vol. 21, Iss. 4, 2005-04 ,pp. : 1-4

Adis International

Access to resources Recommend Favorite

Adalimumab: real life efficacy in rheumatoid arthritis

By  

Inpharma, Vol. 1, Iss. 1454, 2004-01 ,pp. : 13-14

Adis International

Access to resources Recommend Favorite

Adalimumab a PREMIER treatment for early rheumatoid arthritis

By  

Inpharma, Vol. 1, Iss. 1466, 2004-01 ,pp. : 13-14

Adis International

Access to resources Recommend Favorite

Adalimumab improves symptoms and QOL in rheumatoid arthritis

By  

Inpharma, Vol. 1, Iss. 1367, 2002-01 ,pp. : 9-11

Adis International

Access to resources Recommend Favorite

Juvenile Rheumatoid Arthritis: Therapeutic Perspectives

By Chikanza I.C.  

Pediatric Drugs, Vol. 4, Iss. 5, 2002-01 ,pp. : 335-348

Adis International

Access to resources Recommend Favorite